中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2014年
3期
77-78
,共2页
熊艳%张建%刘琴%董守金
熊豔%張建%劉琴%董守金
웅염%장건%류금%동수금
卡孕栓%宫缩素%产后出血
卡孕栓%宮縮素%產後齣血
잡잉전%궁축소%산후출혈
carboprost suppositories%oxytocin%postpartum hemorrhage
目的:探讨分析卡孕栓联合宫缩素预防产后出血的临床疗效。方法:回顾性分析2010年8月至2013年3月间于我院进行正常分娩的224例产妇的临床记录资料。结果:治疗组的产后出血率为2.68%,明显低于于对照组的9.82%;具有显著性差异(P<0.05);治疗组的第三产程时间、产后2h出血量以及产后24h出血量均明显低于对照组,具有显著性差异(P<0.01);两组的收缩压、舒张压和治疗前相比,均无明显变化(P>0.05);用药后两组的收缩压、舒张压相比,也无显著性差异(P>0.05);治疗组的不良反应发生率为8.04%,和对照组的6.25%相比;无显著性差异(P>0.05)。结论:卡孕栓联合宫缩素预防产后出血的临床疗效显著,值得临床推广应用。
目的:探討分析卡孕栓聯閤宮縮素預防產後齣血的臨床療效。方法:迴顧性分析2010年8月至2013年3月間于我院進行正常分娩的224例產婦的臨床記錄資料。結果:治療組的產後齣血率為2.68%,明顯低于于對照組的9.82%;具有顯著性差異(P<0.05);治療組的第三產程時間、產後2h齣血量以及產後24h齣血量均明顯低于對照組,具有顯著性差異(P<0.01);兩組的收縮壓、舒張壓和治療前相比,均無明顯變化(P>0.05);用藥後兩組的收縮壓、舒張壓相比,也無顯著性差異(P>0.05);治療組的不良反應髮生率為8.04%,和對照組的6.25%相比;無顯著性差異(P>0.05)。結論:卡孕栓聯閤宮縮素預防產後齣血的臨床療效顯著,值得臨床推廣應用。
목적:탐토분석잡잉전연합궁축소예방산후출혈적림상료효。방법:회고성분석2010년8월지2013년3월간우아원진행정상분면적224례산부적림상기록자료。결과:치료조적산후출혈솔위2.68%,명현저우우대조조적9.82%;구유현저성차이(P<0.05);치료조적제삼산정시간、산후2h출혈량이급산후24h출혈량균명현저우대조조,구유현저성차이(P<0.01);량조적수축압、서장압화치료전상비,균무명현변화(P>0.05);용약후량조적수축압、서장압상비,야무현저성차이(P>0.05);치료조적불량반응발생솔위8.04%,화대조조적6.25%상비;무현저성차이(P>0.05)。결론:잡잉전연합궁축소예방산후출혈적림상료효현저,치득림상추엄응용。
Objective: To investigate prevention value of carboprost suppositories combined oxytocin for postpartum hemorrhage. Methods: Clinical data of 224 cases of parturient women in our hospital from August 2010 to March 2013 were reviewed. Results: The postpartum hemorrhage rate of treatment group(2.68%) was significantly lower than that of control group(9.82%),with a significant difference (P <0.05). The third stage of labor , postpartum hemorrhage 2h and 24h postpartum hemorrhage of treatment group were significantly lower than that of the control group,(P<0.01). After treatment , the systolic blood pressure and diastolic blood pressure between two groups had no significant difference(P>0.05).The adverse reactions rate of treatment group( 8.04%) was not significant different with that of the control group (6.25%)(P> 0.05).Conclusion:The carboprost suppositories combined oxytocin for postpartum hemorrhage have significant clinical efficacy.